- City Therapeutics priced an upsized 11.1M-share offering at $18 for ~$200M in gross proceeds and begins trading on the Nasdaq Global Market today under ticker CTY. The clinical-stage biotech is developing RNAi therapeutics. Book-runners: Goldman Sachs, Jefferies, Stifel, Oppenheimer. Watch whether it follows Iambic's 18% pop or the recent trend of debuts fading.
- Jio Platforms, the telecom/digital arm of Reliance, opens for subscription Oct 21 and is targeting roughly a $108B valuation — India's biggest listing, surpassing Hyundai Motor India's $2.9B record from 2024. Price band 1,065–1,119 rupees; ~270M fresh shares could raise $3.1–3.2B. Trading expected around Oct 28. Pricing is described as measured to ensure demand — the opposite of an aggressive pop-and-drop setup.
Useful?